Salo O P
Scand J Infect Dis Suppl. 1985;47:67-9.
Peroral acyclovir has been used as long-term prophylactic treatment for frequent recurrences of genital herpes in four clinical studies comprising 172 patients. At a daily dose of 600 to 1 000 mg it seems to be effective in preventing recurrences in a majority of patients. The treatment does not prevent recurrences after the medication is stopped. The treatment seems to be safe for periods up to 4 months. At present it should be used only in carefully selected cases with seriously debilitating symptoms to prevent recurrences during a short period.
在四项涉及172名患者的临床研究中,口服阿昔洛韦已被用作频繁复发性生殖器疱疹的长期预防性治疗。每日剂量为600至1000毫克时,它似乎能有效预防大多数患者复发。停药后该治疗无法预防复发。该治疗在长达4个月的时间内似乎是安全的。目前,它仅应在症状严重且使人衰弱的经过精心挑选的病例中使用,以在短时间内预防复发。